Urinary tract infection
Not yet recruitingEffect of Pivmecillinam vs Placebo on Enterobacterales Urinary Tract and Bloodstream Infections in High‑Risk Kidney Transplant Recipients (Months 1‑6)
Effect of Pivmecillinam vs Placebo on Enterobacterales Urinary Tract and Bloodstream Infections in High‑Risk Kidney Transplant Recipients (Months 1‑6)
- Disease:Urinary tract infection
- Substances:PlaceboPivmecillinam Hydrochloride
Denmark- Participants:18–64 years · 65+ years
- Substances:Placebo
- Sponsor:Region Hovedstaden








